knowledge -WSS

knowledge

author：leisure time 2025-10-02 09:47:20 - browse：498

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb said that it would purchase Mirati Therapeutics, maker of the cancer drug Krazati, for $4.8 billion in cash in a deal that shows the continued interest of large pharmaceutical firms in relatively small “bolt-on” acquisitions.

Bristol said that it would pay $58.00 per share for Mirati, and would hold another $12.00 per share, or a total of $1 billion, to be paid if one of two different applications for an additional use for Krazati is approved within seven years after the merger closes.

Chris Boerner, Bristol’s chief operating officer and CEO-elect, said in a statement that Mirati had several cancer drugs in development that could deliver sales in the latter half of the decade and beyond, when investors worry that Bristol will need new products to sustain its growth.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Smaller biotechs seek to piggyback on weight loss drug boom

knowledge

WSS

Roche acquires Telavant from Roivant, adding experimental IBD treatment

'Brian's Song' at 50 still offers lessons about cancer for today

Smaller biotechs seek to piggyback on weight loss drug boom

How AI can help patients find reliable information about doctors

Failure, not just success, should guide future doctors

STAT Summit: How researchers deal with rejection

focus

knowledge

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

NFL doctors' conflicts of interest could endanger players, report says

Heart attack and stroke risk calculators need revising

Slovenia has suffered its worst

Continuity nursing helped my family in our darkest PICU moments

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

Medical leaders decry Supreme Court decision on affirmative action

Google's generative AI to analyze medical images — and talk to docs

ChatGPT in medicine: STAT answers readers' burning questions

The problems with dementia villages

knowledge

Tuberculosis patients need more than just free medication

St. Louis police protesters begin picking up checks in $4.9 million settlement

How CRISPR works, explained in two minutes

Trump used to be more articulate. What could explain the change?

STAT Readout: Friday, Oct. 20 biotech updates

Merck, Daiichi strike cancer drug pact worth up to $22 billion

knowledge

leisure time

explore

hotspot